Development and validation of a HPTLC method for analysis of Sunitinib malate
暂无分享,去创建一个
[1] B. Gurupadayya,et al. SPECTROPHOTOMETRIC DETERMINATION OF LEVETIRACETAM USING 2, 4-DNP IN PHARMACEUTICAL DOSAGE FORM , 2014 .
[2] J. Sherma,et al. Thin layer chromatography in drug analysis , 2013 .
[3] J. Fisher,et al. Sunitinib LC–MS/MS Assay in Mouse Plasma and Brain Tissue: Application in CNS Distribution Studies , 2013, Chromatographia.
[4] K. VaghelaBhupendrasinh. ANALYTICAL METHOD DEVELOPMENT AND METHOD VALIDATION IN PHARMACEUTICAL DOSAGE FORM , 2013 .
[5] S. Nipanikar,et al. 'HPTLC' an important tool in standardization of herbal medical product: A review , 2013 .
[6] B. Renger,et al. The Frustrated Reviewer — Recurrent Failures in Manuscripts Describing Validation of Quantitative TLC/HPTLC Procedures for Analysis of Pharmaceuticals , 2010, JPC – Journal of Planar Chromatography – Modern TLC.
[7] E. Giovannetti,et al. Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[8] Asmita Kamble,et al. Validated HPTLC method for simultaneous quantitation of paracetamol, diclofenac potassium, and famotidine in tablet formulation. , 2010, Journal of AOAC International.
[9] R. Parveen,et al. Stability-indicating high-performance thin-layer chromatographic method for quantitative determination of omeprazole in capsule dosage form. , 2010, Journal of AOAC International.
[10] S. Sleijfer,et al. Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry. , 2010, Journal of pharmaceutical and biomedical analysis.
[11] G. Milano,et al. A routine feasible HPLC analysis for the anti-angiogenic tyrosine kinase inhibitor, sunitinib, and its main metabolite, SU12662, in plasma. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] J. Sherma. Review of advances in the thin layer chromatography of pesticides: 2006–2008 , 2009, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.
[13] H. Gelderblom,et al. Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[14] I. Darwish,et al. Quantitative Thin-Layer Chromatographic Method for Determination of Amantadine Hydrochloride , 2008, International journal of biomedical science : IJBS.
[15] S. Dhaneshwar,et al. Stability Indicating HPTLC and LC Determination of Dasatinib in Pharmaceutical Dosage Form , 2007 .
[16] W. Berdel,et al. Vascular endothelial growth factor and its receptor as drug targets in hematological malignancies. , 2007, Current drug targets.
[17] P. Musmade,et al. Stability-indicating HPTLC determination of imatinib mesylate in bulk drug and pharmaceutical dosage form. , 2007, Journal of pharmaceutical and biomedical analysis.
[18] S. Bari,et al. QUANTITATIVE ANALYSIS OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY HIGH PERFORMANCE THIN-LAYER CHROMATOGRAPHY WITH ULTRAVIOLET ABSORPTION DENSITOMETRY , 2007 .
[19] J. Sherma. Thin-layer chromatography in food and agricultural analysis. , 2000, Journal of chromatography. A.
[20] B. Renger. Benchmarking HPLC and HPTLC in pharmaceutical analysis , 1999 .
[21] C. Wium,et al. Evaluation of a high-performance thin-layer chromatographic technique for the determination of salbutamol serum levels in clinical trials. , 1992, Journal of chromatography.